Alexandre V Ivachtchenko
Overview
Explore the profile of Alexandre V Ivachtchenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pascua P, Chesnokov A, Nguyen H, Di H, La Cruz J, Jang Y, et al.
Emerg Infect Dis
. 2025 Mar;
31(4).
PMID: 40064473
During 2023-2024, highly pathogenic avian influenza A(H5N1) viruses from clade 2.3.2.1c caused human infections in Cambodia and from clade 2.3.4.4b caused human infections in the Americas. We assessed the susceptibility...
2.
Ivachtchenko A, Khvat A, Shkil D
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273149
Furin, a serine protease enzyme located in the Golgi apparatus of animal cells, plays a crucial role in cleaving precursor proteins into their mature, active forms. It is ubiquitously expressed...
3.
Chesnokov A, Ivashchenko A, Matsuzaki Y, Takashita E, Mishin V, Ivachtchenko A, et al.
Antimicrob Agents Chemother
. 2024 Apr;
68(5):e0172723.
PMID: 38587392
Antiviral susceptibility of influenza viruses was assessed using a high-content imaging-based neutralization test. Cap-dependent endonuclease inhibitors, baloxavir and AV5116, were superior to AV5115 against type A viruses, and AV5116 was...
4.
Ivashchenko A, Jones J, Shkil D, Ivanenkov Y, Pascua P, Penaflor M, et al.
Antiviral Res
. 2023 Aug;
217:105701.
PMID: 37567255
Neuraminidase inhibitors (NAIs) are recommended for influenza treatment and prevention worldwide. The most widely prescribed NAI is oral oseltamivir, while inhaled zanamivir is less commonly used. Using phenotypic neuraminidase (NA)...
5.
Nguyen H, Chesnokov A, La Cruz J, Pascua P, Mishin V, Jang Y, et al.
Antiviral Res
. 2023 Jul;
217:105679.
PMID: 37494978
Clade 2.3.4.4b highly pathogenic avian influenza (HPAI) A(H5N1) viruses that are responsible for devastating outbreaks in birds and mammals pose a potential threat to public health. Here, we evaluated their...
6.
Ivachtchenko A, Ivashchenko A, Shkil D, Ivashchenko I
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37446350
Aprotinin (APR) was discovered in 1930. APR is an effective pan-protease inhibitor, a typical "magic shotgun". Until 2007, APR was widely used as an antithrombotic and anti-inflammatory drug in cardiac...
7.
Ivashchenko A, Zagribelnyy B, Ivanenkov Y, Ivashchenko I, Karapetian R, Kravchenko D, et al.
Molecules
. 2022 Aug;
27(15).
PMID: 35956925
The efficacy of aprotinin combinations with selected antiviral-drugs treatment of influenza virus and coronavirus (SARS-CoV-2) infection was studied in mice models of influenza pneumonia and COVID-19. The high efficacy of...
8.
Ivashchenko A, Morozova M, Vostokova N, Beniashvily A, Bukhanovskaya O, Burminskiy D, et al.
J Psychiatr Res
. 2021 Oct;
143:436-444.
PMID: 34656876
Generalized anxiety disorder (GAD) is associated with an imbalance in the functioning of the stimulating neurotransmitter systems in human's brain. We studied the safety and therapeutic efficacy of aviandr, the...
9.
Ivashchenko A, Azarova V, Egorova A, Karapetian R, Kravchenko D, Krivonos N, et al.
Viruses
. 2021 Jul;
13(7).
PMID: 34199134
COVID-19 is a contagious multisystem inflammatory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We studied the efficacy of Aprotinin (nonspecific serine proteases inhibitor) in combination with...
10.
Ivashchenko A, Mitkin O, Jones J, Nikitin A, Koryakova A, Karapetian R, et al.
J Antimicrob Chemother
. 2020 Dec;
76(4):1010-1018.
PMID: 33367751
Background: The development and clinical implementation of the cap-dependent endonuclease (CEN) inhibitor baloxavir marboxil was a breakthrough in influenza therapy, but it was associated with the emergence of drug-resistant variants....